Piper Jaffray Transitions Rating on AtriCure (ATRC) to Underweight; Risk/Reward Less Attractive
Tweet Send to a Friend
Piper Jaffray & Co. transitions rating on AtriCure (Nasdaq: ATRC) to Underweight.
Piper analyst says, "We now rate AtriCure Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper analyst says, "We now rate AtriCure Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
